Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.87 -0.08 (-4.10%)
As of: Nov 10, 2026 · 11:37 AM EST

Processa Pharmaceuticals (PCSA) Acquisitions (2014)

Updated

Processa Pharmaceuticals (PCSA) recorded Acquisitions of -$6,280 in FY2017.

Analysis

Processa Pharmaceuticals (PCSA) Acquisitions (2014) Analysis & Trends

  • The FY2017 figure is the highest annual Acquisitions since FY2014.
  • Per Business Quant data, PCSA's Acquisitions was -$3,355 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -17.15 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 10.59 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Processa Pharmaceuticals 5.21 Mn -8.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -3,355.00
API Access

Processa Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PCSA&period=max&api_key=YOUR_API_KEY